Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:

Change settings

Find out more about our cookies policy


Hot Topics

View all hot topics


Co-Dev 2015

9-11 February 2015

We're looking forward to speaking at Co-Dev this year, partnering with NuSkin on the subject of creating extended innovation networks to deliver better products.

» Find out more

Drug Delivery Partnerships

28-30 January 2015

Join Sagentia consultants at the 19th Annual Drug Delivery Partnerships conference taking place in Boca Raton, Florida.

» Find out more

Press Releases

Sagentia selected as lead development partner for Chrono Therapeutics’ wearable ‘smart’ smoking cessation device

4 December 2014

Sagentia announces that it is working with Chrono Therapeutics on the development of SmartStop, the world’s first programmable and wearable nicotine delivery device to help people quit smoking. 

» Find out more

Human augmentation: the ‘Goldilocks’ application for robotics?

17 October 2014

Sagentia is speaking today on human augmentation in robotics at RoboBusiness 2014 in Boston. Dr Nick Collier, Sagentia’s Chief Technology Officer, will be presenting to leaders from across the global robotics industry on the opportunity for robotics to augment humans and enable them to do more, better and different.

» Find out more

Press Coverage

In partnership with MIT Technology Review: Mobile Medical Apps - A market on the move

20 November 2014

Published in partnership with MIT Technology Review Sagentia looks at how the demand for remote patient monitoring is creating an exciting opportunity for the emerging area of connected health, and how MMAs may offer particularly apt solutions to the challenges of monitoring patients remotely.

» Find out more

Sagentia and Premaitha partner on commercial software for NGS-based NIPT product

11 August 2014

GenomeWeb interviews Sagentia's SVP Medical, Paul Wilkins, and Premaitha's CEO Stephen Little on the recent announcement that Premaitha has selected Sagentia to develop a custom bioinformatics solution for Premaitha's NGS-based NIPT product. 

» Find out more

Why choose Sagentia?

Experts in complex science & technology

Multidisciplinary, cross sector team approach

Excel at meeting aggressive timescales

Customer friendly approach
to IP

Accreditation to ISO 9001 and ISO 13485

What our clients say:

"We would have no hesitation in working with Sagentia again and have recommended the team for other initiatives"

RSS Feeds

Keep track of site upates using our RSS feeds, click a link below to view the feed.

Press enquiries

For further information and media enquiries please email